Karin Breu

462 total citations
6 papers, 345 citations indexed

About

Karin Breu is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Karin Breu has authored 6 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Karin Breu's work include Alzheimer's disease research and treatments (4 papers), Adenosine and Purinergic Signaling (1 paper) and Autophagy in Disease and Therapy (1 paper). Karin Breu is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Adenosine and Purinergic Signaling (1 paper) and Autophagy in Disease and Therapy (1 paper). Karin Breu collaborates with scholars based in Switzerland, Canada and Slovakia. Karin Breu's co-authors include Markus Tolnay, Michael Sinnreich, Roger M. Nitsch, David T. Winkler, Ludwig Kappos, Michel Goedert, Perrine Castets, Véronique Schaeffer, Graham Fraser and Florence Clavaguera and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Karin Breu

6 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Breu Switzerland	5	192	94	92	57	55	6	345
Thorsten Pflanzner Germany	8	180 0.9×	136 1.4×	56 0.6×	45 0.8×	114 2.1×	9	416
Sheila C. Victório Brazil	10	175 0.9×	90 1.0×	139 1.5×	34 0.6×	54 1.0×	10	387
Bo‐Ran Choi United States	8	168 0.9×	176 1.9×	43 0.5×	73 1.3×	94 1.7×	16	478
Nsikan Akpan United States	9	92 0.5×	252 2.7×	65 0.7×	90 1.6×	47 0.9×	10	416
Enji Zhang South Korea	11	157 0.8×	132 1.4×	51 0.6×	107 1.9×	75 1.4×	19	388
Tajinder S. Dhammu United States	12	137 0.7×	115 1.2×	56 0.6×	41 0.7×	125 2.3×	16	450
Christopher Lovejoy United Kingdom	6	157 0.8×	257 2.7×	35 0.4×	85 1.5×	51 0.9×	10	415
Wen‐Li Ji China	7	92 0.5×	204 2.2×	55 0.6×	75 1.3×	60 1.1×	11	374
Kyoko Iinuma Japan	11	152 0.8×	123 1.3×	30 0.3×	75 1.3×	65 1.2×	24	374
Caterina Ferraina Italy	9	155 0.8×	233 2.5×	76 0.8×	84 1.5×	50 0.9×	10	404

Countries citing papers authored by Karin Breu

Since Specialization

Citations

This map shows the geographic impact of Karin Breu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Breu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Breu more than expected).

Fields of papers citing papers by Karin Breu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Breu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Breu. The network helps show where Karin Breu may publish in the future.

Co-authorship network of co-authors of Karin Breu

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Breu. A scholar is included among the top collaborators of Karin Breu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Breu. Karin Breu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Heitz, Fabrice D., Karin Breu, Heather C. Denroche, et al.. (2023). A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models. Nature Communications. 14(1). 6294–6294. 13 indexed citations

2.

Breu, Karin, Dorothée Abramowski, Florence Clavaguera, et al.. (2015). Amyloid-β in the Cerebrospinal Fluid of APP Transgenic Mice Does not Show Prion-like Properties. Current Alzheimer Research. 12(9). 886–891. 4 indexed citations

3.

Fraser, Graham, Perrine Castets, Véronique Schaeffer, et al.. (2013). Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice. PLoS ONE. 8(5). e62459–e62459. 177 indexed citations

4.

Graubardt, Nadine, René Fahrner, Adrian Keogh, et al.. (2012). Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis. Hepatology. 57(5). 1969–1979. 39 indexed citations

5.

Doehner, Jana, et al.. (2010). Reduced Reelin Expression Accelerates Amyloid- Plaque Formation and Tau Pathology in Transgenic Alzheimer's Disease Mice. Journal of Neuroscience. 30(27). 9228–9240. 100 indexed citations

6.

Zweifel, Martin, Karin Breu, Eberhard L. Renner, et al.. (2005). Restoration of hepatic mast cells and expression of a different mast cell protease phenotype in regenerating rat liver after 70%‐hepatectomy. Immunology and Cell Biology. 83(6). 587–595. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact